Colgan Erin
SEC CIK 1843563 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FTH | Faeth Therapeutics, Inc. | CFO | 67.5K | — | — | 5 | 2022-02-15 | 2024-02-15 |
Most active insiders at FTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 10% | $1.34M | $704.5K |
| 2 | STEPHENSON BRIAN C | CFO | $1.13M | — |
| 3 | Peyer James | 10%, See remarks below | — | $787.8K |
| 4 | Cambrian BioPharma Inc | 10% | — | $787.8K |
| 5 | Parikh Anand Kiran | Pres, CEO, Dir | $55.4K | — |
| 6 | Hahn Stephen M. | Dir | — | — |
Colgan Erin made no open-market trades at FTH in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-16 | 2024-02-15 | FTH | Faeth Therapeutics, Inc. | Colgan Erin | CFO | F - Tax | $0.79 | -3,627 | 67.5K | -5% | -$2,865 |
| 2023-09-11 | 2023-02-15 | FTH | Faeth Therapeutics, Inc. | Colgan Erin | CFO | F - Tax | $1.50 | -10.9K | 68.1K | -14% | -$16.4K | |
| DMA | 2023-03-29 | 2023-02-15 | FTH | Faeth Therapeutics, Inc. | Colgan Erin | CFO | A - Grant | $0.00 | +51.3K | 57.7K | +804% | $0 |
| DM | 2023-02-17 | 2023-02-15 | FTH | Faeth Therapeutics, Inc. | Colgan Erin | CFO | A - Grant | $0.00 | +51.3K | 73.0K | +237% | $0 |
| D | 2022-02-17 | 2022-02-15 | FTH | Faeth Therapeutics, Inc. | Colgan Erin | CFO | A - Grant | $0.00 | +21.0K | 21.7K | +3,061% | $0 |
Purchase Sale Sale after option exercise All abbreviations